Adam Kalbermatten

Adam Kalbermatten is an accomplished executive and venture partner with a diverse background in customer success, commercial development, and business strategy within the healthcare and pharmaceutical sectors. Currently serving as a Limited Partner at GTMfund, Stage 2 Capital, and Santa Barbara Venture Partners since May 2024, Adam previously held leadership roles at BD, including Vice President of Customer Success and Vice President of Commercial Development. Prior experience includes serving as Chief Executive Officer at ZebraSci and various strategic positions at Terumo Medical Corporation and BD. Adam’s early career included a role at Merck. Educational credentials include an MBA in Finance and Healthcare and Pharmaceutical Management from Columbia Business School, as well as Master's and Bachelor's degrees in Engineering from Stevens Institute of Technology.